Remedium Lifecare Intrinsic Value
Remedium Lifecare (REMLIFE) median intrinsic value is ₹2.56 from 8 valuation models (range ₹2–₹3), vs current price ₹0.87 — +194.3% upside (Trading Below Calculated Value), margin of safety 66.0%. Browse REMLIFE cash flow statement for revenue, profit, balance sheet and cash flow data.
REMLIFE Valuation Methods Summary — DCF, Graham Number & P/E
Remedium Lifecare intrinsic value across 8 models vs current price ₹0.87 — upside/downside and value range per method. Also explore REMLIFE price movement history to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2.61 | ₹2.09 - ₹3.13 | +200.0% | EPS: ₹0.40, Sector P/E: 12x |
| Book Value Method | asset | ₹2.17 | ₹1.95 - ₹2.39 | +149.4% | Book Value/Share: ₹11.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1.74 | ₹1.57 - ₹1.91 | +100.0% | Revenue/Share: ₹114.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1.74 | ₹1.57 - ₹1.91 | +100.0% | EBITDA: ₹44.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹2.56 | ₹2.30 - ₹2.82 | +194.3% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹2.61 | ₹2.35 - ₹2.87 | +200.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1.74 | ₹1.57 - ₹1.91 | +100.0% | ROE: 81.8%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹2.61 | ₹2.35 - ₹2.87 | +200.0% | EPS: ₹0.40, BVPS: ₹11.00 |
REMLIFE Intrinsic Value vs Market Price — All Valuation Models
Remedium Lifecare fair value range ₹2–₹3 vs current market price ₹0.87 across 8 valuation models. For current market price and key ratios, visit Remedium Lifecare stock price NSE.
REMLIFE Intrinsic Value Analysis — Undervalued or Overvalued?
Remedium Lifecare median intrinsic value ₹2.56, current price ₹0.87 — Trading Below Calculated Value by 194.3%, margin of safety 66.0%.
What is the intrinsic value of REMLIFE?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Remedium Lifecare (REMLIFE) is ₹2.56 (median value). With the current market price of ₹0.87, this represents a +194.3% variance from our estimated fair value.
The valuation range spans from ₹1.74 to ₹2.61, indicating ₹1.74 - ₹2.61.
Is REMLIFE undervalued or overvalued?
Based on our multi-method analysis, Remedium Lifecare (REMLIFE) appears to be trading below calculated value by approximately 194.3%.
REMLIFE Financial Health — Key Ratios vs Industry Benchmarks
Remedium Lifecare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Debt to Equity Ratio | 39.09 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 81.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 7.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.27x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
REMLIFE Cash Flow Quality — Operating & Free Cash Flow
Remedium Lifecare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-1,135 Cr | ₹-1,135 Cr | Negative Cash Flow | 3/10 |